Financial Performance - The company has incurred losses in nearly every year since inception and anticipates not achieving profits for the foreseeable future[19] - Perspective Therapeutics, Inc. has incurred losses in nearly every year since its inception and anticipates not achieving profits for the foreseeable future[19] Capital Requirements - The company requires substantial additional capital to fund operations, which may be dilutive to shareholders or impose operational restrictions[19] - The company requires substantial additional capital to fund operations, which may be dilutive to shareholders or impose operational restrictions[19] - Perspective anticipates that its cash resources will be sufficient to fund current planned clinical milestones and operational investments into late 2027[11] - The company believes its cash resources are sufficient to fund current planned clinical milestones and operational investments into late 2027[11] Regulatory and Development Challenges - The company has received Fast Track designation for VMT-α-NET and VMT01, but this may not lead to a faster development or regulatory review process[22] - Perspective has received Fast Track designation for its product candidates VMT-α-NET and VMT01, although this may not guarantee a faster development or approval process[22] - The approval processes of regulatory authorities are lengthy and inherently unpredictable, which could harm the company's ability to market its product candidates[19] - The approval processes of regulatory authorities are lengthy and unpredictable, which could significantly harm the company's ability to market its product candidates[19] Competition and Market Acceptance - The company may face intense competition and may not be able to compete successfully in the market[22] - The company may not achieve broad market acceptance among physicians, patients, and healthcare payors, limiting revenue generation from product sales[22] - The company faces intense competition and must prioritize the development of certain drug candidates, which may limit its ability to capitalize on potentially profitable opportunities[22] Operational Risks - The company relies on single vendors for supplies and services used in the development and production of its alpha-particle therapies[19] - The company relies on single vendors for supplies and services, which poses a risk to its development and production capabilities[19] - The company has in-sourced part of its research and development functions, which may affect operational efficiency and expected cost savings[22] - The company has in-sourced part of its research and development functions, which may affect operational efficiency and cost savings[22] - Significant disruptions of information technology systems or cybersecurity incidents could materially adversely affect the company's business and financial condition[22] Manufacturing Infrastructure - The company expects its manufacturing infrastructure to meet future clinical trial and commercial demands at major treatment centers[11] - Perspective expects its manufacturing infrastructure to meet future clinical trial and commercial demands at major treatment centers[11]

Acquisition and Market Strategy - VMware was acquired by Broadcom on November 22, 2023, leading to changes in the go-to-market approach that affected the commercial relationship with VMware[31]. Financial Performance and Investments - Dell Financial Services funded $11.9 billion of originations in Fiscal 2026 and maintains a $14.3 billion global portfolio of financing receivables[34]. - Total R&D expenses were $3.1 billion for both Fiscal 2026 and Fiscal 2025, and $2.8 billion for Fiscal 2024, reflecting a commitment to innovation[37]. - Strategic investments in non-marketable securities amounted to $1.6 billion as of January 30, 2026, compared to $1.5 billion in the previous year[39]. - Demand for AI-optimized servers drove backlog growth during Fiscal 2026, with traditional servers and networking offerings also experiencing increased demand[45]. - Approximately 40% of net revenue in Fiscal 2026 was generated through other sales channels, highlighting the importance of channel partnerships[54]. Intellectual Property and R&D Management - The company holds a worldwide portfolio of 25,859 granted patents and 8,189 pending patent applications as of January 30, 2026[57]. - The company aims to leverage strategic partnerships to manage R&D expenses and focus on solutions deemed most valuable to customers[37]. - The company continues to evaluate opportunities for strategic investments in emerging technology areas relevant to its business[38]. Environmental and Social Responsibility - The company’s operations are subject to various environmental and safety regulations, with no material environmental fines reported during Fiscal 2026[61]. - The company is committed to sustainability, integrating circularity principles throughout its value chain to improve resource efficiency and environmental benefits[65]. - The company actively addresses climate-related risks by managing greenhouse gas emissions across its operations, supply chain, and product lifecycle[66]. - The company monitors its supply chain for adherence to the Responsible Business Alliance Code of Conduct, utilizing third-party audits to ensure responsible manufacturing practices[75]. - The company is committed to upholding human rights and ensuring that it and its suppliers do not engage in human rights violations[77]. Workforce and Talent Management - As of January 30, 2026, the company had approximately 97,000 employees, with ongoing efforts to reduce costs through employee reorganizations and limiting external hiring[68]. - The company aims to attract, develop, and retain top talent through competitive compensation, training, and development programs, demonstrating its commitment to human capital management[67][70]. - The company has implemented a comprehensive benefits program to support employees' physical, mental, emotional, and financial well-being, reinforcing a healthy work-life balance[72]. - The company engages with employees through initiatives like the annual Tell Dell survey to foster connection and improve the employee experience[73]. Strategic Focus and Technology Areas - The company has a strategic focus on emerging technology areas such as Cloud, Edge, Telecom, and as-a-Service, shaping its long-term strategy[83]. Financial Risk Management - Dell Technologies' borrowings exposed to interest rate fluctuations were $3.0 billion as of January 30, 2026, relative to total borrowings of $31.5 billion[354]. - A 100 basis point increase in interest rates would result in an increase of approximately $30 million in annual interest expense based on the debt outstanding as of January 30, 2026[354]. - The company held strategic investments in non-marketable securities valued at $1.6 billion as of January 30, 2026, compared to $1.5 billion as of January 31, 2025[357]. - The maximum potential one-day loss in fair value at a 95% confidence level for foreign currency hedge instruments was approximately $6 million as of January 30, 2026[350]. - Dell Technologies' interest rate risk exposure is limited to fluctuations in interest rates on unhedged borrowings, which were $3.0 billion as of January 30, 2026[353]. - The company utilizes foreign currency option contracts and forward contracts to hedge its exposure on forecasted transactions and firm commitments for certain currencies[349]. - Interest expense on borrowings under securitization programs is recognized within interest and other, net, while interest income is recognized to net revenue over time[352]. - As of January 31, 2025, borrowings exposed to interest rate fluctuations were $2.6 billion relative to total borrowings of $24.6 billion[355]. - A 100 basis point increase in interest rates would have resulted in an increase of approximately $26 million in annual interest expense based on the debt outstanding as of January 31, 2025[355]. - Dell Technologies employs established policies and procedures to manage various market risks, including foreign currency exchange rate fluctuations and interest rate changes[348].

Financial Performance - For the fiscal year ended January 31, 2026, the company's revenue was $1,618.6 million, up from $1,249.2 million in the previous fiscal year, representing a growth of approximately 29.5%[43] - The company incurred a net loss of $9.1 million for the fiscal year ended January 31, 2026, resulting in an accumulated deficit of $1,619.1 million[110] - The company increased its operating expenses to $1,294.7 million for the fiscal year ended January 31, 2026, compared to $1,140.9 million for the fiscal year ended February 1, 2025[138] - Approximately 14% of total revenue in fiscal year 2026 was generated from international markets, highlighting growth potential outside the United States[63] - Subscription revenue is recognized ratably over the term of contracts, meaning changes in sales or renewals may not be immediately reflected in revenue, affecting future financial performance[230] Customer Base and Engagement - As of January 31, 2026, the company had over 12,000 Core Customers, each contributing $25,000 or more in annual recurring revenue (ARR), with approximately 85% of total ARR coming from these customers[38] - The company focuses on larger customers, with 3,194 large customers each representing over $100,000 in ARR, accounting for approximately 61% of total ARR[38] - As of January 31, 2026, over 90% of Core Customers and over 95% of customers with over $100,000 in ARR subscribed to multiple Applications, indicating strong cross-sell opportunities[60] - Customer subscription renewals are critical, with contracts typically lasting three to five years, and past instances of non-renewal have been noted[116] - The company’s free-trial sales model builds trust and demonstrates the platform's capabilities, aiding in customer acquisition[84] Product and Technology Development - The Data Platform processed over 25 trillion data points in fiscal year 2026, enabling significant AI-driven insights for operational improvements[39] - The Connected Operations Platform integrates data from IoT devices and third-party systems, providing a unified view of operations and enabling actionable insights[45] - The platform's AI-powered insights help customers achieve higher asset utilization and lower operational costs, including reduced insurance costs and emissions[39] - The Connected Operations Platform is designed to support enterprise-grade physical operations, utilizing edge computing for real-time data processing[53] - The company is investing significantly in AI technology to enhance its Connected Operations Platform, but risks associated with AI, such as flawed algorithms and data quality issues, could impact its reputation and operating results[155] Operational Efficiency and Impact - A Fortune Global 500 logistics company using the platform achieved a 65% decrease in harsh driving incidents and a 49% reduction in accident-related costs[42] - One of the largest flooring manufacturers saved over $7 million annually by reducing total mileage by 25% through route optimization[46] - A top retailer in Canada saved 46,000 gallons of fuel, equating to a reduction of 469 metric tons of CO2 emissions in just four months[46] - The Connected Operations Platform helped prevent thousands of driving accidents, digitized millions of processes, and eliminated billions of pounds of CO2 emissions in fiscal year 2026[53] - The Connected Asset Maintenance application enables a shift from reactive repairs to data-driven preventative maintenance, maximizing asset uptime[68] Market and Competitive Landscape - The company expects additional competition as its market grows and may choose to enter or expand into new markets[93] - Intense competition exists in the market, with various vendors offering similar solutions, impacting demand for the company's offerings[127] - The company may face increased competition from established and emerging companies, which could lead to reduced margins and loss of market share[130] - The company emphasizes the importance of maintaining a superior pace of innovation to support its competitive position in the market[93] - The competitive position of the Connected Operations Platform relies on compatibility with a wide variety of data sources and infrastructure, which is critical for maintaining business performance[162] Regulatory and Compliance Risks - The company is subject to various laws and regulations, including those governing privacy, data security, and ELD certification, which may impact its operations and compliance costs[100] - The company faces risks from various U.S. privacy laws, which could lead to costly investigations and significant liability[214] - Regulatory compliance is critical, as failure to comply with laws and regulations could result in significant penalties and harm customer relationships[203] - The company has obtained certification for all of its ELD models in Canada, but failure to maintain this certification could negatively impact its reputation and customer base[203] - Increased regulatory scrutiny in the technology industry may lead to substantial fines and changes in business practices, adversely affecting the company's operations[208] Intellectual Property and Legal Matters - The company holds a portfolio of 202 issued patents and 16 allowed patents pending issuance in the United States, with expiration dates ranging from 2035 to 2044[95] - The company has filed lawsuits against competitors for patent infringement and trade secret misappropriation, indicating an active approach to protecting its intellectual property[189] - Ongoing litigation related to intellectual property rights could be costly and may distract management from core business priorities[188] - The company may face challenges in enforcing its intellectual property rights, particularly in jurisdictions with less protective laws[185] - Future acquisitions may increase the company's exposure to intellectual property risks, as there may be less visibility into the development processes of acquired technologies[193] Growth Strategy and Challenges - The company aims to expand its customer base and increase application adoption, leveraging a customer-centric innovation approach[60] - The growth strategy includes selling additional subscriptions to existing customers, but success depends on anticipating industry evolution and enhancing existing applications[117] - The company relies heavily on direct sales, with plans to expand its sales organization domestically and internationally, particularly targeting large organizations[119] - Effective management of growth is essential, as rapid revenue growth has placed demands on management and operational resources[126] - The ability to attract new customers depends on timely enhancements and new technologies for the Connected Operations Platform, which may not achieve market acceptance[139] Supply Chain and Operational Risks - The ongoing global silicon component shortage has resulted in increased costs and delays in shipments, affecting the company's IoT devices[132] - The company relies on a limited number of joint design manufacturers and suppliers, which may adversely affect its ability to sell subscriptions to its Connected Operations Platform and impact margins[132] - The company faces risks from geopolitical tensions, particularly between China and Taiwan, which could disrupt its supply chain and manufacturing operations[133] - Disruptions in cellular and satellite networks could impede the functionality of the company's solutions, affecting profitability and operational results[159] - The company may experience lost sales opportunities or delayed revenue due to insufficient supply and inventory management of its IoT devices[136]

Assets Under Management (AUM) - Discretionary assets under management (AUM) decreased by 1.2% in Q4 2025, from $24.3 billion to $24.0 billion, while total discretionary AUM increased by 3% year-over-year to $24.0 billion[2]. - Total AUM decreased by 1.6% in Q4 2025 to $37.0 billion, but increased by 2% year-over-year from $36.5 billion[4]. - Total assets under management (AUM) at the end of Q4 2025 were $37.0 billion, up 1.4% from $36.5 billion at the end of Q4 2024[46]. - Total AUM as of December 31, 2025, is $37.044 billion, an increase from $36.455 billion as of December 31, 2024, representing a growth of 1.6%[52]. - Total Discretionary AUM at December 31, 2025, is $23.982 billion, compared to $23.319 billion at the end of 2024, indicating a growth of 2.8%[52]. - Discretionary AUM at the end of Q4 2025 was $24.0 billion, a 3.0% increase from $23.3 billion at the end of Q4 2024[48]. - Non-discretionary AUM decreased to $13.0 billion at the end of Q4 2025, down 1.5% from $13.2 billion at the end of Q4 2024[50]. Revenue and Income - Revenue for Q4 2025 was flat at $32.0 million compared to Q4 2024, while total revenue for the year increased by 1.3% to $125.3 million[18][22]. - Net income attributable to Silvercrest for 2025 was $4.9 million, down 48.7% from $9.5 million in 2024[35]. - Basic net income per share for 2025 was $0.56, compared to $1.00 in 2024, reflecting a 44% decrease[35]. - The company reported a net loss of $0.1 million for the three months ended December 31, 2025, compared to a net income of $2.7 million in the same period of 2024[37]. - The company reported a GAAP net loss of $(107) million for Q4 2025, compared to a net income of $2,684 million in Q4 2024[41]. Expenses - Total expenses increased by 9.5% in Q4 2025 to $32.8 million, driven primarily by a 12.1% increase in compensation and benefits expense[19]. - Total expenses for 2025 were $116.0 million, an increase of 9.3% from $106.0 million in 2024[35]. - Silvercrest's compensation and benefits expense for the full year 2025 was $83.9 million, representing 67.0% of revenue, compared to 62.0% in 2024[10][23]. EBITDA - Adjusted EBITDA for Q4 2025 was $2.9 million, or 8.9% of revenue, down from $5.1 million, or 15.9% of revenue, in Q4 2024[21]. - For the full year 2025, adjusted EBITDA was $19.6 million, or 15.7% of revenue, compared to $26.1 million, or 21.1% of revenue, in 2024[25]. - Adjusted EBITDA for the year ended December 31, 2025, was $19.6 million, a decrease of 25% compared to $26.1 million in 2024[39]. - Adjusted EBITDA Margin for 2025 was 15.7%, down from 21.1% in 2024[39]. Client Accounts and Flows - Silvercrest added $124.5 million in organic new client accounts in Q4 2025, totaling $688.3 million for the full year, marking one of the strongest acquisition levels in recent years[3]. - Gross client inflows for Q4 2025 were $1.4 billion, down 36.4% from $2.2 billion in Q4 2024[46]. - Net client flows for Q4 2025 were negative at $(0.8) billion, compared to positive net flows of $0.9 billion in Q4 2024, indicating a significant shift[46]. - New client accounts/assets for the twelve months ended December 31, 2025, totaled $0.688 billion, down from $1.549 billion in 2024, reflecting a decrease of 55.6%[52]. - Closed accounts for the same period were $0.403 billion, a decrease from $0.527 billion in 2024, showing a reduction of 23.5%[52]. Cash and Equity - Cash and cash equivalents were $44.1 million at the end of 2025, down from $68.6 million at the end of 2024[26]. - Silvercrest's total equity was $50.3 million as of December 31, 2025[27]. - The company’s total equity decreased to $84,884 million at the end of Q4 2025, down from $119,693 million at the end of Q4 2024[44]. Future Outlook - The company plans to host a conference call on March 17, 2026, to discuss these results, indicating ongoing communication with investors[29].

Financial Performance - Total revenue for Adecoagro S.A. in 2025 was $1,427.7 million, a decrease of 6% compared to $1,518.9 million in 2024[25] - Profit from operations decreased to $94.3 million in 2025, down 48% from $182.3 million in 2024[25] - The company reported a net loss of $6.8 million for 2025, compared to a profit of $92.1 million in 2024[25] - Earnings per share attributable to equity holders of the parent were $(0.082) in 2025, a decline from $0.900 in 2024[25] - Total comprehensive income for 2025 was $11,896 thousand, down from $237,226 thousand in 2024 and $155,096 thousand in 2023[27] - The company reported a loss of $8.348 million for the year 2025, with total comprehensive income amounting to $9.632 million after accounting for other comprehensive income[37] - The company reported a profit from operations of $256,125,000 in 2025, compared to $60,066,000 in 2024[125] Revenue and Costs - The cost of revenue in 2025 was $1,178.5 million, slightly down from $1,198.7 million in 2024[25] - The cost of revenue in 2025 was $1,195,299 thousand, leading to a gross profit margin of approximately 17.4% compared to 21.2% in 2024[120] - The total cost of revenue for Adecoagro S.A. in 2025 was $1,178,507 thousand, with the largest segment being Sugar, Ethanol, and Energy at $482,747 thousand[131] - The cost of production of manufactured products for 2025 was $941,318 thousand, with Dairy contributing $226,388 thousand, which represents approximately 24% of the total production cost[136] Assets and Liabilities - Total assets reached $5,248,798 thousand in 2025, a substantial increase from $3,114,888 thousand in 2024[28] - Total liabilities increased to $3,456,507 thousand in 2025, compared to $1,706,787 thousand in 2024, largely due to higher borrowings[28] - Non-current assets increased to $3,829,702 thousand in 2025, up from $2,099,886 thousand in 2024, primarily due to a rise in property, plant, and equipment[28] - Current assets rose to $1,419,096 thousand in 2025, compared to $1,015,002 thousand in 2024, driven by an increase in trade and other receivables[28] Borrowings and Financing - Borrowings rose to $1,379,921 thousand in 2025, significantly up from $680,005 thousand in 2024[28] - The Group's total borrowings as of December 31, 2024, were $779.6 million, indicating a significant increase in borrowings by 104.5% by 2025[73] - The Group's net cash used in financing activities was $785,774 thousand in 2025, a notable change from a net cash outflow of $274,000 thousand in 2024[41] Shareholder Equity - Shareholders' equity attributable to equity holders of the parent grew to $1,655,342 thousand in 2025, up from $1,369,150 thousand in 2024[28] - As of December 31, 2025, the total shareholders' equity reached $1.792 billion, an increase from $1.408 billion in 2024[37] - The company issued capital of $303.687 million in 2025, following a reduction of issued share capital of $9 million[37] Economic Environment - Argentina's annual inflation rate was reported at 31.5% for 2025, a decrease from 117.8% in 2024 and 211.4% in 2023, indicating a volatile economic environment[49] - The official exchange rate against the U.S. dollar increased by 40.9% in 2025, compared to 27.7% in 2024 and 356.3% in 2023, reflecting currency fluctuations impacting operations[49] Segment Performance - The Group now operates in three segments: Sugar, Ethanol and Energy, Fertilizers, and Farming, with segment information regularly reviewed by the Chief Operating Decision Maker (CODM)[107] - The total revenue for the Farming segment was reported at $1,445,904, with adjustments leading to a final figure of $1,427,734[115] - The Dairy segment reported a revenue of $293,289, adjusted to $283,916 after accounting for expenses[115] Biological Assets - The fair value of the company's level 3 biological assets was $259 million as of December 31, 2025[13] - The total biological assets at the end of 2025 were valued at $314,744 thousand, up from $293,945 thousand at the end of 2024, reflecting an increase in sugarcane and rice assets[187] - The initial recognition and changes in fair value of biological assets for 2025 totaled $95,610 thousand, significantly higher than the $143,081 thousand recorded in 2024[182] Taxation - The Group's profit before income tax resulted in an income tax expense of $174 thousand for 2025, a significant decrease from $57,015 thousand in 2024 and a loss of $78,673 thousand in 2023[154] - The total deferred income tax liability as of December 31, 2025, was $(824,374) thousand, an increase from $(416,034) thousand in 2024[148] Cash Flow - The company experienced a decrease in cash generated from operating activities, totaling $308,518 thousand in 2025 compared to $328,331 thousand in 2024[41] - Cash and cash equivalents increased to $383,150 thousand in 2025, compared to $211,244 thousand in 2024, indicating improved liquidity[28] Risk Management - The Group's financial risk management includes hedging certain expected cash flows with foreign exchange derivative contracts[59] - The Group's liquidity risk management involves maintaining sufficient cash and ensuring the availability of funding from committed credit facilities[69]

Financial Performance - Full-year revenue reached $981.3 million, a 4.5% increase year-over-year, marking the highest revenue in the company's 30-year history[5] - Q4 revenue was $282.3 million, up 14.1% year-over-year, with Creative revenue at $149.0 million (up 4.6%) and Editorial revenue at $109.4 million (up 21.4%) [6] - Net loss for Q4 2025 was $90.9 million, compared to a net income of $24.7 million in Q4 2024, resulting in a net loss margin of 32.2%[6] - Adjusted EBITDA for 2025 was $320.9 million, a 6.9% increase year-over-year, with an adjusted EBITDA margin of 32.7%[10] - Net loss for the year ended December 31, 2025, was $206,183 thousand compared to a net income of $39,472 thousand in 2024[35] - Total revenue for the three months ended December 31, 2025, was $282,287 thousand, representing a 14.1% increase from $247,324 thousand in 2024[43] - Adjusted EBITDA for the twelve months ended December 31, 2025, was $320,863 thousand, up from $300,271 thousand in 2024, reflecting a margin of 32.7%[40] - Free Cash Flow for the twelve months ended December 31, 2025, was $5,672 thousand, a decrease from $60,870 thousand in 2024[42] Debt and Liquidity - Total debt stood at $2.7 billion, including $1.2 billion in Senior Secured Notes and $300 million in senior unsecured notes[10] - Current liabilities increased to $1.31 billion in 2025 from $453.3 million in 2024, primarily due to short-term debt and litigation reserves[33] - The accumulated deficit reached $1.43 billion as of December 31, 2025, compared to $1.22 billion in 2024, highlighting ongoing financial challenges[33] - Total liquidity decreased to $240.2 million as of December 31, 2025, down from $259.5 million as of September 30, 2025, and $271.2 million as of December 31, 2024[45] - Cash and cash equivalents declined to $90.2 million as of December 31, 2025, compared to $109.5 million as of September 30, 2025, and $121.2 million as of December 31, 2024[45] - Short-term debt increased to $696.5 million as of December 31, 2025, compared to $21.1 million as of September 30, 2025[45] - Senior secured notes rose to $1,168.3 million as of December 31, 2025, up from $539.9 million as of September 30, 2025[45] - Excluded from total liquidity is restricted cash of $635.1 million as of December 31, 2025[45] Customer Metrics - Annual subscription revenue as a percentage of total revenue decreased to 48.6% in Q4 2025 from 54.9% in Q4 2024, primarily due to significant licensing agreements[6] - Total purchasing customers decreased by 3.9% to 689,000, and total active annual subscribers fell by 11.4% to 278,000[12] Strategic Initiatives - The merger with Shutterstock has received regulatory clearance in all jurisdictions except the UK, where a final report is due by June 14, 2026[5] - The proposed merger with Shutterstock, Inc. is a strategic move aimed at enhancing market position and operational capabilities[27] - Getty Images is focusing on expanding its capabilities through generative AI technologies, enhancing its creative library and content solutions[23] Operational Challenges - The company expects 2026 revenue guidance between $948 million and $988 million, reflecting a year-over-year decline of 3.4% to 0.6%[14] - The company anticipates a challenging comparison for 2026 due to approximately $40 million of revenue recognized in an accelerated manner in Q4 2025[14] - The company is facing risks related to competition, customer retention, and the ability to manage growth effectively, which could impact future performance[26] Other Financial Metrics - Total operating expenses for Q4 2025 were $306.4 million, compared to $211.4 million in Q4 2024, reflecting a significant increase due to litigation losses[31] - The company reported a total asset value of $3.24 billion as of December 31, 2025, up from $2.56 billion in 2024[33] - The company reported a net cash provided by operating activities of $65,190 thousand for the year ended December 31, 2025, down from $118,320 thousand in 2024[35] - The company incurred a payment of debt totaling $1,037,040 thousand during the financing activities for the year ended December 31, 2025[35] - Adjusted diluted earnings per share for the three months ended December 31, 2025, was $(0.01), compared to $0.02 in 2024[41] - The company experienced a foreign currency loss of $56,948 thousand for the year ended December 31, 2025, compared to a gain of $(28,411) thousand in 2024[35] Shareholder Information - The weighted-average Class A common shares outstanding were approximately 416.1 million for Q4 2025, slightly up from 411.4 million in Q4 2024[31]

User Engagement and Growth - Zedge reported 20.4 million monthly active users (MAU) as of January 31, 2026, a key performance indicator for the Zedge App [111]. - The Zedge Marketplace generated revenue through advertising, in-app sales of Zedge Credits, and a subscription offering, with approximately 1.2 million active subscribers as of January 31, 2026 [114]. - Zedge introduced pAInt, a generative AI wallpaper maker, in fiscal 2023, enhancing user engagement through text-to-image and other creative functionalities [112]. - The Creator Economy, which Zedge is part of, is estimated to be worth between $191 billion and $250 billion globally in 2025, presenting significant growth opportunities [110]. Financial Performance - Total revenues for the company increased by 18.3% to $8.254 million for the three months ended January 31, 2026, compared to $6.979 million in the same period last year [143]. - Subscription revenue for the Zedge App increased by 32.5% to $1.634 million for the three months ended January 31, 2026, compared to $1.233 million in the same period last year [144]. - Average Revenue Per Monthly Active User (ARPMAU) for the Zedge App increased by 47.5% to $0.1146 for the three months ended January 31, 2026, driven by higher advertising prices and strong subscription revenue growth [130]. - Advertising revenue for the three months ended January 31, 2026, increased by 18.3%, primarily due to higher average prices per advertising impression [150]. Operational Challenges - The company recorded a non-cash impairment charge of approximately $3.7 million to reduce the carrying amount of the Emojipedia assets group due to competitive pressures from AI developments [108]. - GuruShots, acquired by Zedge, has faced revenue decline and is undergoing a restructuring plan to improve user acquisition and retention [121]. - Zedge's operations are significantly impacted by geopolitical tensions, particularly in Israel, which may affect business performance and workforce availability [106]. Cost Management - Selling, general and administrative expenses decreased by 6.2% to $6.683 million for the three months ended January 31, 2026, compared to $7.126 million in the same period last year [143]. - Stock-based compensation expense decreased by 54.4% to $275,000 for the three months ended January 31, 2026, compared to $603,000 in the same period of 2025 [169]. - Direct cost of revenues increased by 25.5% to $561,000 for the three months ended January 31, 2026, compared to $447,000 in the same period last year [143]. Subscription Metrics - Active subscriptions at the end of the period reached 1,175,000, reflecting a 48.5% increase from 791,000 in the prior year [147]. - For the six months ended January 31, 2026, subscription revenue increased by 30.6% to $2,415,000 compared to $1,850,000 in the same period of 2025 [157]. - Subscription billings, a non-GAAP measure, increased by 2.0% to $1,908,000 for the three months ended January 31, 2026, compared to $1,871,000 in the same period of 2025 [148]. Loss and Impairment - Net loss for the company increased by 36.3% to $2.289 million for the three months ended January 31, 2026, compared to a net loss of $1.679 million in the same period last year [143]. - The company recorded an impairment charge of $3.7 million for the quarterly results ended January 31, 2026, due to anticipated reduced traffic and revenue from changes in search engine results [124]. - For the three months ended January 31, 2026, the Zedge Marketplace segment reported a loss from operations of $2.1 million, compared to income of $41,000 in the prior year, primarily due to impairment charges of $3.7 million [188][189]. Cash Flow and Capital Management - Cash and cash equivalents stood at $19.1 million as of January 31, 2026, with working capital of $15.3 million, compared to $18.6 million and $14.7 million, respectively, at July 31, 2025 [193]. - Net cash provided by operating activities was $1.7 million for the six months ended January 31, 2026, reflecting a net loss of $1.5 million adjusted for non-cash items of $4.4 million [196]. - The company maintains a revolving credit facility of $4 million, including a foreign exchange contract facility of up to $7.5 million [193]. Customer Concentration - One large customer represented 34% of total revenue for the six months ended January 31, 2026, compared to 31% in the same period of 2025 [205]. - At January 31, 2026, two customers represented 33% and 19% of the accounts receivable balance, respectively, compared to 48% and 13% at July 31, 2025 [205]. Workforce and Restructuring - Global headcount as of January 31, 2026, totaled 85, down from 106 as of January 31, 2025, indicating a reduction in workforce [169]. - The GuruShots segment's loss from operations decreased by 65.6% to $777,000 for the three months ended January 31, 2026, compared to $2.3 million in the prior year, attributed to lower SG&A expenses [190].

Company Overview - Kyntra Bio rebranded from FibroGen, Inc. in January 2026, with its common stock trading under the new Nasdaq symbol "KYNB" [28]. - The company closed the sale of its China operations to AstraZeneca for a total consideration of $220.4 million, including $85.0 million in enterprise value and $135.4 million in net cash [30]. Product Development - Kyntra Bio is developing FG-3246, a potential first-in-class ADC targeting CD46 for mCRPC, with a Phase 2 monotherapy dose optimization study initiated in Q3 2025 [28][40]. - The ongoing Phase 2 trial of FG-3246 aims to enroll 75 patients, with interim results expected in the second half of 2026 [42]. - In a prior Phase 1 study, FG-3246 demonstrated a confirmed objective response rate of 20% and a disease control rate of 80% in mCRPC patients [44]. - Kyntra Bio is heavily reliant on the commercial success of its lead products, roxadustat and FG-3246, with ongoing development for metastatic castration-resistant prostate cancer (mCRPC) using the PET imaging agent FG-3180 [145]. Roxadustat Overview - Roxadustat is currently approved in multiple countries for treating anemia in CKD patients, with significant unmet medical needs in lower-risk MDS patients [29][54]. - The FDA granted Roxadustat Orphan Drug Designation for the treatment of MDS in December 2025, with a positive Type-C meeting held in July 2025 regarding the Phase 3 study design for anemia associated with lower-risk MDS [33][32]. - Roxadustat stimulates the body's natural RBC production and iron hemostasis, providing a potential safe and convenient option for lower-risk MDS patients [54]. - The company has retained rights to roxadustat in the U.S., Canada, and Mexico, while Astellas is responsible for commercialization in Europe and Japan [64]. Clinical Trials and Regulatory Approvals - The Phase 3 trial for roxadustat is planned to include approximately 200 patients with lower-risk MDS, focusing on RBC transfusion independence as a primary endpoint [59]. - In the Phase 2/3 clinical trial, 47.5% of patients in the roxadustat arm achieved transfusion independence for 56 consecutive days compared to 33.3% in the placebo arm, although the p-value was not significant [61]. - The FDA requires a 60-day review period after NDA or BLA submission acceptance, during which it assesses product safety, efficacy, and manufacturing compliance [90]. - Post-approval, drugs remain under FDA regulation, including recordkeeping and reporting of adverse experiences [91]. Financial Aspects - The company received $49.8 million from a revenue interest financing agreement with NovaQuest related to future revenues from Astellas' sales of roxadustat [77]. - The global MDS market was estimated at approximately $3 billion in 2023 and is projected to reach approximately $5 billion by 2030, reflecting a CAGR of about 9% from 2024 to 2030 [55]. Intellectual Property - Roxadustat composition-of-matter patents are set to expire in 2024 in most regions, except in the U.S. where they will expire in 2025, while additional patents related to its crystalline form and key intermediates will expire in 2033 [124]. - The European Patent No. 3470397 for roxadustat formulations has been granted, extending patent protection to 2036 [125]. - FG-3246 patent portfolio includes patents expiring in 2035 for composition-of-matter and in 2041 for pharmaceutical compositions and dosing [126]. - The company may apply for patent term restoration under the Hatch-Waxman Act, potentially extending patent life by up to five years [111]. Compliance and Regulatory Risks - Compliance with various data privacy laws, such as the CCPA and EU GDPR, imposes significant obligations and potential penalties for noncompliance [101]. - The company faces risks from healthcare reform measures that may reduce reimbursement and impose pricing pressures [107]. - Regulatory approval processes vary significantly across countries, affecting the timeline for product launches in international markets [109]. - The company must ensure compliance with rigorous regulatory standards throughout the clinical trial process to maintain credibility and protect trial participants [149]. Employee Engagement and Diversity - As of December 31, 2025, the company had 34 employees in the U.S., with a 100% participation rate in a recent employee engagement survey [133][135]. - The company achieved a 96% positive employee sentiment regarding diversity, equity, and inclusion in 2025, up from 86% in 2024 [135]. - The Board of Directors consists of 20% female members and 20% identifying as Asian ethnicity, with the U.S. workforce being 45% female [138]. Market Challenges - The company faces substantial competition in the development and commercialization of product candidates, particularly in the prostate cancer market [173]. - Market acceptance of product candidates is uncertain, and inadequate reimbursement from payors may limit attractiveness to patients and providers [180]. - The company may need to conduct additional clinical trials to obtain or maintain reimbursement or pricing approval in various countries [184]. Supply Chain and Manufacturing Risks - The company relies on third-party manufacturers for production and distribution, which may lead to reduced control and potential delays in commercialization [196]. - Supply chain logistics, including importing materials from countries like China and India, add risks of delays and potential shortages [204]. - The company relies on single-source suppliers for certain components, and loss of these suppliers could materially affect business operations [203]. Legal and Regulatory Compliance - Compliance with healthcare fraud and abuse laws is critical, as violations could lead to substantial penalties and affect the company's financial results [223]. - Legal proceedings related to healthcare regulations may incur significant expenses and distract management, potentially adversely affecting share prices [225]. - The company is subject to stringent data privacy and security laws, with non-compliance leading to regulatory actions and reputational harm [226].

Revenue Composition - Getty Images' annual subscriptions represented more than half of total revenue as of December 31, 2025, indicating a significant shift towards subscription products [23]. - Creative content accounted for 56.7% of revenue in 2025, with 58.2% of that generated through annual subscription products [26]. - Editorial content contributed 37.7% of revenue in 2025, with 53.5% derived from annual subscription products [26]. - The corporate market contributed approximately 59% of revenue in 2025, highlighting a strong focus on this segment for future growth [29]. - The company paid over $220 million in royalties to content contributors in 2025, with approximately 75% of revenue generated from exclusive content [4]. Customer Metrics - The company added over 365,000 new customers during the year ended December 31, 2025, demonstrating strong customer acquisition efforts [30]. - Customer acquisition cost decreased by over 15% since 2019, reaching $146 in 2025, reflecting improved marketing efficiency [34]. - Total purchasing customers decreased to 689 thousand for the LTM ended December 31, 2025, compared to 717 thousand in 2024 and 799 thousand in 2023, attributed to a decline in iStock subscriptions [414]. - Total active annual subscribers decreased to 278 thousand for the LTM ended December 31, 2025, compared to 314 thousand in 2024, but increased from 236 thousand in 2023, with declines driven by iStock subscriptions [416]. - Annual revenue per purchasing customer grew by 8.7% to $1,424 for the LTM ended December 31, 2025, up from $1,310 in 2024 [414]. - LTM annual subscriber revenue retention rate was 89.9% for the year ended December 31, 2025, down from 92.9% in 2024 and 92.4% in 2023 [412]. Content and Assets - Getty Images has a growing library of over 645 million total assets, providing unmatched depth and quality to meet customer needs [28]. - The company has over 600,000 contributors, with more than 83,000 being exclusive to Getty Images, enhancing its content offerings [27]. - The company maintains one of the largest privately-owned photographic archives in the world, with over 150 million images, which serves as a key differentiator [10]. - Image collection increased to 609 million as of December 31, 2025, up from 572 million in 2024 and 535 million in 2023 [412]. - Video collection increased to 36 million as of December 31, 2025, compared to 32 million in 2024 and 28 million in 2023 [412]. Financial Performance - For the year ended December 31, 2025, cash provided by operating activities was $65.2 million, a decrease of 44.9% compared to $118.3 million in 2024, primarily due to merger-related costs of $45.7 million [374]. - Cash used in investing activities for 2025 was $59.5 million, down 17.9% from $72.5 million in 2024, attributed to the acquisition of Motorsport Images LLC and Motorsport.com, Inc. in the prior year [378]. - Financing activities provided $576.2 million in 2025, a significant increase of 1124.9% compared to cash used of $56.2 million in 2024, driven by proceeds from debt issuance and common stock [379]. - Adjusted EBITDA for the year ended December 31, 2025, was $320.9 million, with an Adjusted EBITDA margin of 32.7% [426]. - Net loss for the year ended December 31, 2025, was $206.2 million, compared to a net income of $39.5 million in 2024 [429]. - Adjusted net loss income for the year ended December 31, 2025, was $(11.1) million, down from $49.0 million in 2024 [429]. - Diluted earnings per share for the year ended December 31, 2025, was $(0.50), compared to $0.10 in 2024 [429]. Strategic Initiatives - In 2023, Getty Images launched a generative AI image tool, designed to be commercially safe and trained on its creative content [33]. - The company launched Generative AI by Getty Images in 2023 and plans to launch Generative AI by iStock in early 2024, focusing on commercially safe AI text-to-image generation services [6]. - The company is actively investing in digital marketing and localization to penetrate high-growth geographies, aiming to capture increased market share [37]. - The company has a successful track record of executing and integrating strategic acquisitions to leverage content and accelerate growth [7]. - The company may evaluate potential acquisitions and investments as part of its growth strategy, depending on market conditions [372]. Market Environment - The competitive landscape includes various digital content providers, with principal competitors being Adobe, Shutterstock, and generative AI services like Midjourney and Dall-E [8]. - The Nebraska, New Hampshire, and New Jersey Data Privacy Acts, among others, regulate how the company collects and processes personal data, which may impact operations [71]. - The company is subject to evolving tax regulations, including the Tax Cuts and Jobs Act of 2017, which may materially affect financial results [372]. - The company expects changes from the One Big Beautiful Bill Act (OBBBA) to reduce its annual U.S. tax liability and cash taxes in 2025 and 2026 [372]. Operational Insights - Video attachment rate decreased to 15.9% for the year ended December 31, 2025, down from 16.5% in 2024, with approximately 33% of Getty Images and 13% of iStock customers purchasing video [1]. - LTM paid download volume was 92 million for the year ended December 31, 2025, compared to 93 million in 2024 and 95 million in 2023 [412]. - Paid download volume decreased slightly for the LTM ended December 31, 2025, compared to the prior years, indicating steady demand despite macro-economic challenges [418]. - The video attachment rate decreased to 15.9% in the LTM ended December 31, 2025, from 16.5% in the prior year, reflecting lower volumes of video downloaders on the iStock platform [423]. - The company had no material letters of credit outstanding or other off-balance sheet arrangements as of December 31, 2025, 2024, and 2023 [390]. - The company does not believe that inflation has had a material effect on its business, financial condition, or results of operations [391].

Revenue Breakdown - FutureFuel's revenue for the year ended December 31, 2025, was distributed across three primary categories: Custom Manufacturing (54%), Biofuels (38%), and Performance Chemicals (8%) [22] - The Chemicals segment accounted for 62% of total revenue in 2025, with significant contributions from custom manufacturing and performance chemicals [24] - Revenue for the fiscal year ended December 31, 2025, was $95,742, a decrease of $147,597 or 61% compared to $243,339 in 2024 [210] - Revenue from the United States for the fiscal year ended December 31, 2025, was $94,790, while revenue from foreign countries was $952, totaling $95,742 [205] Biofuels Segment - In 2025, the biofuels segment produced 9 million gallons of biodiesel, a significant decrease from 45 million gallons in 2024, due to regulatory uncertainties [22] - The company’s biofuels operations are significantly influenced by governmental programs, with the BTC providing a $1.00 per gallon refundable tax credit, which is set to be replaced by the CFPC in 2025 [106] - The top two customers in the biofuel segment contributed 32% of revenue in 2025, down from 44% in 2023, indicating a diversification in the customer base [60] - Sustainable Aviation Fuel (SAF) production nearly doubled in January 2025, reaching 16.4 million gallons, highlighting its emergence as a growth leader in the biofuels sector [55] - The biodiesel market is characterized by significant competition from renewable diesel, which often commands a premium price due to its superior properties and market integration [63] Production Capacity - FutureFuel's facility has a demonstrated capacity of approximately 59 million gallons per year (MMgy) for biodiesel production [22] - The company’s annual biodiesel production capacity is 59 million gallons per year [199] - Biodiesel production capacity in the U.S. decreased to 1,995 million gallons per year in late 2024, down from 2,083 million gallons in 2023, while renewable diesel capacity surged to 4,580 million gallons from 3,897 million gallons [53] Financial Performance - Loss from operations for the fiscal year ended December 31, 2025, was $(52,990), a decline of $59,362 from an income of $6,372 in 2024 [210] - Net loss for the fiscal year ended December 31, 2025, was $(49,397), down $64,900 from a net income of $15,503 in 2024 [210] - Adjusted EBITDA for the fiscal year ended December 31, 2025, was $(38,317), a decrease of $59,634 from $21,317 in 2024 [210] Customer Concentration - Three chemical customers represented greater than 10% of total sales revenue in 2025, accounting for 48% of total revenue, indicating a shift in customer concentration compared to 2024 [31] - The chemical business is concentrated with three large customers, representing 81% of the chemicals segment product sales, which poses a risk if any of these customers are lost [132] Regulatory Environment - The company transitioned from the Blenders' Tax Credit to the Clean Fuel Production Credit effective January 1, 2025, which subsidizes fuels based on their greenhouse gas emission levels [45] - The biodiesel industry is facing regulatory challenges, with the expiration of the BTC and the introduction of the CFPC creating uncertainty in operating margins [72] - The Clean Fuel Production Credit (CFPC) is expected to be finalized before mid-year 2026, transitioning the industry away from the traditional BTC [207] - Incentives favoring renewable diesel over traditional biodiesel are expected to affect future revenue projections due to higher renewable fuel value [207] Operational Challenges - The company is exposed to operating risks common to chemical manufacturing, including fires, explosions, and natural disasters, which could materially affect sales revenue and financial condition [130] - The company has experienced increasingly frequent unscheduled service utility downtimes due to supplier delays and quality issues, which may negatively impact operations [131] - The availability of transportation for biodiesel distribution is limited, which may hinder access to more lucrative markets and restrict cash flow from sales [123] Research and Development - Research and development expenses for 2025 were $3,866 million, a decrease from $4,398 million in 2023, primarily focused on developing new products and improving existing processes [80] Environmental Impact - Environmental protection expenditures in 2025 totaled $7,862 million, a decrease from $12,854 million in 2023, attributed to reduced waste treatment requirements [83] - Nitrogen oxide emissions from biodiesel may harm its appeal as a renewable fuel, potentially increasing costs and affecting marketability [128] Strategic Initiatives - FutureFuel is expanding its market footprint through a dual-track strategy of diversification and vertical integration, enhancing its supply chain and creating new revenue streams [19] - The company is positioned to expand into higher-value segments, including pharmaceutical intermediates and food-grade ingredients, by integrating GMP capabilities alongside existing ISO certifications [33] - The company is developing a Responsible AI & LLM Governance Policy to enhance operational precision and safety in manufacturing [96] Financial Management - The company has entered into a $35 million revolving credit facility, expiring in February 2030, with no outstanding borrowings as of the report date [149] - The company has approximately $5.5 million in cash balances exceeding FDIC insurance limits as of December 31, 2025 [161] - The company has identified a material weakness in internal control over financial reporting, which has been remediated but poses ongoing risks [153] Stock and Shareholder Information - The company has 43,863,507 shares of common stock outstanding as of March 16, 2026 [177] - The company declared and paid regular cash dividends for 2025 and 2024, with dividends also declared for Q1 2026 [179] - The board authorized a stock repurchase program of up to $25.0 million, with a 24-month extension announced on December 10, 2025 [189]